THE ATOPIC DERMATITIS CONTROL TOOL TO MEASURE LONG-TERM CONTROL OF ATOPIC DERMATITIS IN KOREAN PATIENTS UNDERGOING DUPILUMAB TREATMENT: A RETROSPECTIVE SINGLE-CENTRE ANALYSIS OVER 3 YEARS

被引：0
|
作者：
Bae, In Ho [1 ]
Choi, Hoon [1 ]
Kim, Min Sung [1 ]
Shin, Bong Seok [1 ]
Na, Chan Ho [1 ]
机构：
[1] Chosun Univ, Coll Med, Dept Dermatol, Gwangju, South Korea
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P9.8
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [21] What Does Long-Term Control in Atopic Dermatitis Look Like?
    Narla, Shanthi
    Fuxench, Zelma C. Chiesa
    Abuabara, Katrina
    Beck, Lisa A.
    Chovatiya, Raj
    Thaci, Diamant
    Silverberg, Jonathan I.
    DERMATITIS, 2025,
  • [22] Comment on "Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry"
    Seo, Hyun-Min
    Oh, Se Uk
    Park, Se Kwang
    Kim, Joung Soo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : E171 - E171
  • [23] Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study
    Alexa B. Kimball
    Dimittri Delevry
    Min Yang
    Chien-Chia Chuang
    Zhixiao Wang
    Gaëlle Bégo-Le-Bagousse
    Bruno Martins
    Eric Wu
    Brad Shumel
    Jessie Wang
    Debra Sierka
    Jingdong Chao
    Bruce Strober
    Dermatology and Therapy, 2023, 13 : 2107 - 2120
  • [24] Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study
    Kimball, Alexa B.
    Delevry, Dimittri
    Yang, Min
    Chuang, Chien-Chia
    Wang, Zhixiao
    Bego-Le-Bagousse, Gaelle
    Martins, Bruno
    Wu, Eric
    Shumel, Brad
    Wang, Jessie
    Sierka, Debra
    Chao, Jingdong
    Strober, Bruce
    DERMATOLOGY AND THERAPY, 2023, 13 (09) : 2107 - 2120
  • [25] Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control
    Blauvelt, Andrew
    Langley, Richard G.
    Peris, Ketty
    Silvestre, Juan Francisco
    Katoh, Norito
    Tauber, Marie
    Pinter, Andreas
    Ameen, Mahreen
    Gooderham, Melinda
    Oland, Christian Bjerregard
    Tindberg, Ann-Marie
    Gjerum, Le
    Reich, Kristian
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II48 - II49
  • [26] Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study
    Torres, Tiago
    Cruz, Maria Joao
    Goncalo, Margarida
    Filipe, Paulo
    Duarte, Bruno
    Alves, Joao
    Alvarenga, Jose Miguel
    Rosa, Gilberto
    Flor, Duarte
    Ramos, Jose
    Sousa, Diogo
    Rosca, Aureliu
    Magalhaes, Cesar
    Claro, Cristina
    Rocha, Joana
    Vilarinho, Catarina
    Mota, Fernando
    Mota, Alberto
    Lopes, Maria Joao Paiva
    DERMATOLOGY AND THERAPY, 2024, 14 (08) : 2209 - 2221
  • [27] Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients
    Nettis, E.
    Fabbrocini, G.
    Ortoncelli, M.
    Pellacani, G.
    Argenziano, G.
    Di Leo, E.
    Patruno, C.
    Stingeni, L.
    Foti, C.
    Rongioletti, F.
    Macchia, L.
    Tavecchio, S.
    Napolitano, M.
    Ribero, S.
    Bonzano, L.
    Calabrese, G.
    Di Bona, D.
    Nistico, S. P.
    Hansel, K.
    Romita, P.
    Piras, V.
    Carbonara, M.
    Detoraki, A.
    Ferrucci, S. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : 561 - 563
  • [28] Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'''
    Bosma, Angela L.
    de Wijs, Linde E. M.
    Hof, Michel H.
    Middelkamp-Hup, Beau R. van Nieuwenhui-Maritza A.
    Gerbens, Louise A. A.
    Middelkamp-Hup, Maritza A.
    Hijnen, Dirk-Jan
    Spuls, Phyllis I.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : E173 - E174
  • [29] Real-world effectiveness and safety of nemolizumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study
    Miyawaki, Kayo
    Nakashima, Chisa
    Otsuka, Atsushi
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (06) : 691 - 692
  • [30] A single-centre real-life experience on effectiveness and safety of dupilumab in adolescents with severe atopic dermatitis in treatment with cyclosporine A
    Colonna, C.
    Zussino, M.
    Ponziani, A.
    Gelmetti, C.
    Monzani, N. A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (08) : E533 - E535
12345